{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:22:54Z","timestamp":1787768574662,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Cold agglutinin disease (CAD) is relatively rare and has primarily been reported as retrospective case series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIM:<\/jats:title>\n                    <jats:p>We reviewed our experience with CAD to shed light on this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SETTINGS AND DESIGN:<\/jats:title>\n                    <jats:p>This was a retrospective review of all patients with CAD managed at our institution between 2007 and 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>The study was approved by our institutional review board. We extracted patients\u2019 demographic, clinical, and laboratory data, blood transfusions, and outcomes from their electronic medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STATISTICAL ANALYSIS USED:<\/jats:title>\n                    <jats:p>Statistical analysis was performed using SPSS version 17. The method of Kaplan\u2013Meier was used to plot survival curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Forty-eight patients fulfilled the inclusion criteria for CAD. The median age of patients was 73.1 (range, 43\u201399) years; 36 (75%) were female. The majority (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 38; 79.2%) of patients were Caucasians. Most patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 25, 52.1%) presented with symptomatic anemia. Eight patients were asymptomatic. The median hemoglobin level was 8.6 g\/dL (range, 3\u201312 g\/dL); 7 (14.6%) patients had concurrent thrombocytopenia. Lactate dehydrogenase was elevated in 40\/47 (85.1%) patients and haptoglobin was below normal in 35\/46 (76.1%) patients. Coagulopathy was observed in 19 (52.8%) of 36 patients. Sixteen (33.3%) patients required blood transfusion during admission at the time of diagnosis with a median number of 3.5 red blood cell units. Twenty-five (52.1%) patients were alive after a median follow-up of 50.1 months. The 5-year and 10-year survival was estimated at 58.2% and 30.8%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>CAD poses considerable burden on patients and health-care systems. Patients vary widely in their disease severity and course.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_65_23","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T03:01:36Z","timestamp":1705374096000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and laboratory characteristics of patients with cold agglutinin disease: A retrospective analysis at a tertiary medical center"],"prefix":"10.4103","volume":"17","author":[{"given":"Harshita","family":"Mehrotra","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaher K.","family":"Otrock","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI, USA"},{"name":"Department of Pathology, Wayne State University School of Medicine, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2013-02-474437","article-title":"Cold agglutinin disease","volume":"122","author":"Swiecicki","year":"2013","journal-title":"Blood"},{"key":"R2-20240830","first-page":"439","article-title":"Cold agglutinin disease","volume":"91","author":"Gertz","year":"2006","journal-title":"Haematologica"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JBM.S177621","article-title":"Cold agglutinin disease:Current challenges and future prospects","volume":"10","author":"Berentsen","year":"2019","journal-title":"J Blood Med"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2991\/chi.k.200706.001","article-title":"Cold agglutinin disease","volume":"2","author":"Gabbard","year":"2020","journal-title":"Clin Hematol Int"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev"},{"key":"R6-20240830","first-page":"460","article-title":"Primary chronic cold agglutinin disease:A population based clinical study of 86 patients","volume":"91","author":"Berentsen","year":"2006","journal-title":"Haematologica"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/bloodadvances.2017004390","article-title":"Cold agglutinin disease burden:A longitudinal analysis of anemia, medications, transfusions, and health care utilization","volume":"1","author":"Mullins","year":"2017","journal-title":"Blood Adv"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/bloodadvances.2019000476","article-title":"Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease","volume":"3","author":"Bylsma","year":"2019","journal-title":"Blood Adv"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults:Recommendations from the first international consensus meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours:Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited:A multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12185-020-02899-6","article-title":"Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan","volume":"112","author":"Kamesaki","year":"2020","journal-title":"Int J Hematol"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/rth2.12333","article-title":"Increased risk of thrombotic events in cold agglutinin disease:A 10-year retrospective analysis","volume":"4","author":"Broome","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"R16-20240830","first-page":"1419","article-title":"An observational analysis of disease burden in patients with cold agglutinin disease:Results from a large US electronic health record database","volume":"28","author":"Pham","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ejh.13710","article-title":"Thromboembolic complications in autoimmune hemolytic anemia:Retrospective study","volume":"108","author":"Sch\u00e4r","year":"2022","journal-title":"Eur J Haematol"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bjh.13183","article-title":"New perspectives on the thrombotic complications of haemolysis","volume":"168","author":"L'Acqua","year":"2015","journal-title":"Br J Haematol"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin:A novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOH.0000000000000423","article-title":"Hemolysis and immune regulation","volume":"25","author":"Zhong","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5045\/br.2016.51.2.88","article-title":"Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia:A single center study from South India","volume":"51","author":"Prabhu","year":"2016","journal-title":"Blood Res"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_65_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:15:08Z","timestamp":1787768108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_65_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_65_23","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-03-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}